Changes at PTI, a new CEO at CROS and SCM Pharma’s US expansion head up the executive changes in this week’s Outsourcing-pharma.com’s People on the Move column.
Andrew MacGarvey has been appointed CEO and President of CROS NT, a contract research organization specialising in clinical data services.
The role was previously held by Paolo Morelli, who has moved into the position of Chairman.
Morelli said "I am pleased to appoint Andrew as CEO of CROS NT, it is the culmination of a two-year plan. Andrew has overseen our expansion into the UK and US and his combination of commercial and operational knowledge, alongside his passion for customer service, makes him the right candidate to take CROS NT forward.
“Andrew understands that we are a people business and I am confident he will continue to grow the company in a sustainable way. He has built a great team to support him and I look forward to watching them in the next phase of the CROS NT story."
MacGarvey was VP of CROS NT for the past two years, following 13 years in senior positions at contract manufacturing and research organisations including Quanticate, Datatrial and PRA International.
Copyright - Unless otherwise stated all contents of this web site are © 2017 - William Reed Business Media SAS - All Rights Reserved - Full details for the use of materials on this site can be found in the Terms & Conditions
From a new administration under president-elect Donald Trump, to continued consolidation, the CRO and CMO industry can...
As 2016 comes to a close, Outsourcing-Pharma.com looks back at some of the major mergers and acquisitions...
Quintiles has opened the global Solution Design Studio at its campus in Research Triangle Park in North...
Eli Lilly is conducting several experiments on the International Space Station (ISS) US National Laboratory over the...